ZA200103156B - Methods of downmodulating the immune response to therapeutic proteins. - Google Patents

Methods of downmodulating the immune response to therapeutic proteins.

Info

Publication number
ZA200103156B
ZA200103156B ZA200103156A ZA200103156A ZA200103156B ZA 200103156 B ZA200103156 B ZA 200103156B ZA 200103156 A ZA200103156 A ZA 200103156A ZA 200103156 A ZA200103156 A ZA 200103156A ZA 200103156 B ZA200103156 B ZA 200103156B
Authority
ZA
South Africa
Prior art keywords
downmodulating
methods
immune response
therapeutic proteins
proteins
Prior art date
Application number
ZA200103156A
Inventor
Jiahua Qian
Leon W Hoyer
Mary Collins
Gary S Gray
Original Assignee
Genetics Inst
American Nat Red Cross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst, American Nat Red Cross filed Critical Genetics Inst
Publication of ZA200103156B publication Critical patent/ZA200103156B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/37Factors VIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4846Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA200103156A 1998-09-21 2001-04-18 Methods of downmodulating the immune response to therapeutic proteins. ZA200103156B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15817898A 1998-09-21 1998-09-21

Publications (1)

Publication Number Publication Date
ZA200103156B true ZA200103156B (en) 2002-07-18

Family

ID=22566971

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200103156A ZA200103156B (en) 1998-09-21 2001-04-18 Methods of downmodulating the immune response to therapeutic proteins.

Country Status (21)

Country Link
EP (1) EP1115423A1 (en)
JP (1) JP2002526455A (en)
KR (1) KR20010085830A (en)
CN (1) CN1331602A (en)
AU (1) AU761206B2 (en)
BR (1) BR9913991A (en)
CA (1) CA2343916A1 (en)
CZ (1) CZ20011021A3 (en)
EA (1) EA005236B1 (en)
HK (1) HK1039059A1 (en)
HU (1) HUP0103960A3 (en)
IL (1) IL142069A0 (en)
LT (1) LT4920B (en)
LV (1) LV12768B (en)
MX (1) MXPA01002898A (en)
NO (1) NO20011412L (en)
NZ (1) NZ511034A (en)
PL (1) PL346796A1 (en)
SI (1) SI20626A (en)
WO (1) WO2000016801A1 (en)
ZA (1) ZA200103156B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
DE60118362T2 (en) * 2000-05-19 2007-05-24 The Center for Blood Research, Inc., Boston METHOD FOR TREATING HEMOSTATIC INTERFERENCE BY SOLUBLE P-SELECTIN
EP1636579A4 (en) * 2003-06-10 2011-10-05 Smiths Detection Inc Sensor arrangement
GB201508024D0 (en) * 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171569A (en) 1985-03-15 1992-12-15 National Research Development Corporation Factor IX preparations uncontaminated by plasma components or pox virus
US4868112A (en) 1985-04-12 1989-09-19 Genetics Institute, Inc. Novel procoagulant proteins
US5422260A (en) 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
US4994371A (en) 1987-08-28 1991-02-19 Davie Earl W DNA preparation of Christmas factor and use of DNA sequences
FR2657884B1 (en) 1990-02-05 1994-09-02 Tm Innovation PROCESS FOR THE PREPARATION OF HUMAN FACTOR VIII AND FACTOR VIII ANALOGS.
US5661008A (en) 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
US5770197A (en) 1991-06-27 1998-06-23 Bristol-Myers Squibb Company Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
KR100238712B1 (en) 1991-06-27 2000-01-15 스티븐 비. 데이비스 Method for regulating the immune response using b7 binding molecules and il4-binding molecules
WO1993009804A1 (en) 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
US5744446A (en) 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
US5364771A (en) 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
US5663060A (en) 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
WO1996005860A1 (en) * 1994-08-19 1996-02-29 Novo Nordisk A/S A method of treating a patient with a biologically active compound
JPH10507758A (en) * 1994-10-19 1998-07-28 ジェネティック セラピー,インコーポレイテッド Gene therapy with simultaneous administration of adenovirus and immunosuppressive drugs
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
PT892643E (en) * 1996-03-20 2002-09-30 Univ Emory METHODS FOR INHIBITING AN IMMUNITY RESPONSE BLOCKING THE GP39 / CD40 AND CTLA4 / CD28 / B7 CIRCUITS AND USES FOR THE EFFECT
ATE356634T1 (en) * 1997-01-10 2007-04-15 Biogen Idec Inc METHOD FOR THERAPEUTIC ADMINISTRATION OF ANTI-CD40L AGENTS
TR199903141T2 (en) * 1997-06-20 2000-09-21 Biogen, Inc. CD154 blockade therapy for therapeutic protein blocker syndrome.
US8099877B2 (en) 2009-11-06 2012-01-24 Hexagon Metrology Ab Enhanced position detection for a CMM

Also Published As

Publication number Publication date
CA2343916A1 (en) 2000-03-30
AU761206B2 (en) 2003-05-29
LT4920B (en) 2002-06-25
MXPA01002898A (en) 2002-06-04
HK1039059A1 (en) 2002-04-12
LV12768B (en) 2002-06-20
EP1115423A1 (en) 2001-07-18
HUP0103960A2 (en) 2002-02-28
BR9913991A (en) 2001-07-03
KR20010085830A (en) 2001-09-07
LT2001045A (en) 2002-01-25
IL142069A0 (en) 2002-03-10
WO2000016801A1 (en) 2000-03-30
PL346796A1 (en) 2002-02-25
CN1331602A (en) 2002-01-16
HUP0103960A3 (en) 2003-09-29
SI20626A (en) 2002-02-28
JP2002526455A (en) 2002-08-20
NO20011412D0 (en) 2001-03-20
NO20011412L (en) 2001-05-16
EA005236B1 (en) 2004-12-30
AU6057899A (en) 2000-04-10
NZ511034A (en) 2004-03-26
WO2000016801A9 (en) 2000-10-26
CZ20011021A3 (en) 2001-10-17
EA200100385A1 (en) 2001-10-22
LV12768A (en) 2001-12-20

Similar Documents

Publication Publication Date Title
ZA983451B (en) Substituted imidazoles useful in the treatment of inflammatory diseases.
ZA200006312B (en) Antibodies to CD23, derivatives thereof, and their therapeutic uses.
IL161823A0 (en) Antibodies to cd40 and pharmaceutical compositionscontaining the same
ID24118A (en) COMBINED THERAPY
ID27841A (en) THERAPEUTIC BIARILS
ID28441A (en) THERAPY TO IMPROVE CONSCIOUSNESS
ID21379A (en) HIDDEN RITSLETING ASSOCIATED WHICH CAN BE SEPARATED UNTIL DOWN STOP
FI971500A0 (en) thermos
TR199501501A2 (en) Preparation of the sugars.
DE69819465D1 (en) PLEASURE INVESTMENT
DE69601919T2 (en) PERCOLATOR
ZA200103156B (en) Methods of downmodulating the immune response to therapeutic proteins.
AU6604701A (en) Method to induce the TH1 immune response
IT1303907B1 (en) GASOGEN TO INCREASE THE PROJECTILE RANGE
GB9822619D0 (en) Immune response stimulation
AU2001245815A1 (en) Human immune response proteins
GB0014437D0 (en) Immune response stimulation
AU6074000A (en) Human immune response molecules
GB0109114D0 (en) Stimulation of the immune system
FR2758470B1 (en) THE WEARER
FR2770129B1 (en) THE ROWING ARMCHAIR
TW369896U (en) Modified walker structure
NO965332D0 (en) Therapeutic preparation
BR7701932U (en) Double thermos
GB9811365D0 (en) Double walker